CYTOSORB THERAPY REGAIN CONTROL
Live / Applied — Fourth extension granted (statement of use) (as of 15 Jan 2026)
What this means for you
Not registered yet, but its 17 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97844109
- Mark type
- Stylized text
- Filed
- 17 Mar 2023
- Published for opposition
- 05 Dec 2023
- Attorney of record
- Kevin M. Bovard
Goods and services
- Class 010 — Medical apparatus: Medical devices, namely, adsorption and absorption materials and systems for treating the blood of patients who are at risk of or who have medically destabilizing conditions such as the systemic inflammatory response syndrome SIRS, sepsis and infection, other immunologic conditions, or organ dysfunction or failure
Owner
- CYTOSORBENTS CORPORATION, Princeton, NJ, US
- CYTOSORBENTS CORPORATION, Princeton, NJ, US
Prosecution history
- 16 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jan 2026 — SOU EXTENSION 4 GRANTED
- 15 Jan 2026 — SOU EXTENSION 4 FILED
- 15 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jul 2025 — SOU EXTENSION 3 GRANTED
- 08 Jul 2025 — SOU EXTENSION 3 FILED
- 08 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Dec 2024 — SOU EXTENSION 2 GRANTED
- 30 Dec 2024 — SOU EXTENSION 2 FILED
- 30 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 09 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2024 — SOU EXTENSION 1 GRANTED
- 09 Jul 2024 — SOU EXTENSION 1 FILED